Table 1 Functional annotation of miR-150-targeted genes
Functional annotation | Target gene | %a | P-value |
---|---|---|---|
GO category | |||
 Small-molecule metabolic process | POM121, PISD, STX1A, AMD1, PRKCA, NDST1, ACSL4 | 16.67 | 0.001 |
 Fibroblast growth factor receptor signaling pathway | FOXO4, PRKCA, NDST1 | 7.14 | 0.001 |
 Positive regulation of transcription from RNA polymerase II promoter | FOXO4, IKZF1, TET3, NFIC, RUNX1 | 11.9 | 0.002 |
 Regulation of translational initiation | EIF4B, CTIF | 4.76 | 0.002 |
 Epidermal growth factor receptor signaling pathway | GRB7, FOXO4, PRKCA | 7.14 | 0.003 |
 Polysaccharide biosynthetic process | NDST1 | 2.38 | 0.004 |
 S-adenosylmethioninamine biosynthetic process | AMD1 | 2.38 | 0.004 |
 Negative regulation of prostaglandin secretion | ACSL4 | 2.38 | 0.004 |
 Forward locomotion | TTN | 2.38 | 0.004 |
 DNA demethylation of male pronucleus | TET3 | 2.38 | 0.004 |
 Positive regulation of neutrophil differentiation | IKZF1 | 2.38 | 0.004 |
 Regulation of vasculature | FZD4 | 2.38 | 0.004 |
 Alpha-tubulin acetylation | ATAT1 | 2.38 | 0.004 |
 Positive regulation of dense core granule biogenesis | PRKCA | 2.38 | 0.004 |
 In utero embryonic development | TTN, RUNX1, TANC2 | 7.14 | 0.004 |
 mRNA transport | POM121, POM121C | 4.76 | 0.005 |
 Forebrain development | NDST1, IKZF1 | 4.76 | 0.006 |
 Histone H3-T6 phosphorylation | PRKCA | 2.38 | 0.008 |
 Progesterone secretion | FZD4 | 2.38 | 0.008 |
 Positive regulation of Golgi to plasma membrane protein transport | CNST | 2.38 | 0.008 |
 RNA metabolic process | EIF4B, PRKCA, PDCD4 | 7.14 | 0.008 |
 Neurotrophin TRK receptor signaling pathway | PRKCA, ARHGEF2, FOXO4 | 7.14 | 0.009 |
 Positive regulation of angiogenesis | PRKCA, RUNX1 | 4.76 | 0.011 |
 Apoptotic signaling pathway | PRKCA, ARHGEF2 | 4.76 | 0.016 |
Pathway | |||
 Proteoglycans in cancer | PDCD4, PRKCA, FZD4, EIF4B | 9.52 | 0.0002 |
 RNA transport | POM121C, POM121, EIF4B | 7.14 | 0.002 |
 Pathogenic Escherichia coli infection | ARHGEF2, PRKCA | 4.76 | 0.005 |
 mTOR signaling pathway | PRKCA, EIF4B | 4.76 | 0.006 |
 Amphetamine addiction | PRKCA, STX1A | 4.76 | 0.008 |
 Insulin secretion | PRKCA, STX1A | 4.76 | 0.012 |
 Pathways in cancer | FZD4, RUNX1, PRKCA | 7.14 | 0.015 |
 Melanogenesis | FZD4, PRKCA | 4.76 | 0.017 |
 Wnt signaling pathway | FZD4, PRKCA | 4.76 | 0.033 |